ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646199; 2) Community: the network communities that were significantly associated with the response to NSC 646199; 3) Molecule: the relationships between components within communities and NSC 646199; 4) MDR: the compounds that were significantly associated with the NSC 646199.

NSC Compound Enrichment Correlation
NSC 5337 Pyridinium, 1-dodecyl-, salt with 5-chloro-2-benzothiazolethiol (1:1) (8CI) 0.03551961774939 0.23423724
NSC 628688 Null 0.03551961774939 0.21693572
NSC 628690 Null 0.03551961774939 0.30438226
NSC 630703 Acridomide 0.03551961774939 0.33024359
NSC 636476 cis-Difluorobis[1-(phenyl-2,4,6-trimethyl)butane-1,3- dionato]titanium(IV) 0.03551961774939 0.17321741
NSC 651084 1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-[methoxy(acetyloxy)]-7-methyl- 0.0388857481216096 0.37874705
NSC 655105 Cycloshikonin 0.0388857481216096 0.466171
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.0388857481216096 0.37162863
NSC 670558 Null 0.0388857481216096 0.19308937
NSC 670802 Null 0.0388857481216096 0.38934
Total:68  Current:45    [First] [Prev] [Next] [Last]